Financhill
Back

Evolent Health Quote, Financials, Valuation and Earnings

7 Powerhouse Stocks to Buy and Hold Forever

Get it now.
Buy
62

EVH
Evolent Health

Last Price:
29.61
Seasonality Move:
24.1%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Evolent Health Price Quote

$29.61
-0.01 (-0.1%)
(Updated: April 19, 2024 at 4:37 AM ET)

Evolent Health Key Stats

Buy
62
Evolent Health (EVH) is a Buy

Day range:
$29.39 - $30.51
52-week range:
$23.33 - $36.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.68
P/B ratio:
3.16%

Volume:
826.9K
Avg. volume:
734.9K
1-year change:
-15.18%
Market cap:
$3.4B
Revenue:
$2B
EPS:
$-1.27

How Much Does Evolent Health Make?

Is Evolent Health Growing As A Company?

  • What Is Evolent Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.45%
  • What Is Evolent Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Evolent Health Stock Price Performance

  • Did Evolent Health Stock Go Up Last Month?
    Evolent Health share price went down by -7.93% last month
  • Did EVH's Share Price Rise Over The Last Year?
    EVH share price fell by -15.18% over the past 1 year

What Is Evolent Health 52-Week High & Low?

Evolent Health Price To Free Cash Flow

Is It Risky To Buy Evolent Health?

  • How Much Debt Does Evolent Health Have?
    Total long term debt quarterly is $597M
  • How Much Cash Does Evolent Health Have?
    Cash and short term investments quarterly total is $192.8M
  • What Is Evolent Health’s Book Value Per Share?
    Book value per share is 9.38

Is Evolent Health Cash Flow Positive?

  • What Is EVH Cash Flow From Operations?
    Cash flow from operations (TTM) is $142.6M
  • What Is Evolent Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $281.3M
  • What Is Evolent Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$415.5M

Evolent Health Return On Invested Capital

  • Is Management Doing A Good Job?
    EVH return on invested capital is -6.82%
  • What Is Evolent Health Return On Assets?
    ROA measures how assets are converting to revenues and is -4.56%
  • What Is EVH Return On Equity?
    ROE is a measure of profitability and is -10.45%

Evolent Health Earnings Date & Stock Price

Evolent Health Competitors

  • Who Are Evolent Health's Competitors?
    Below is a list of companies who compete with Evolent Health or are related in some way:
    • American Shared Hospital Services (AMS)
    • Astrana Health Inc (ASTH)
    • Cryo-Cell International Inc (CCEL)
    • Novo Integrated Sciences Inc (NVOS)
    • P3 Health Partners Inc (PIII)

Evolent Health Dividend Yield

Data Unavailable

Evolent Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.26%
Revenue: 45.4% 2.5%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 45.23
Upside from Last Price: 52.7%

Major Shareholders

  • How many EVH shares are owned by institutional investors?
    213.1M EVH shares are owned by institutional investors
  • How many EVH shares are owned by insiders?
    3.8M EVH shares are owned by insiders